Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Jul 22;9:111. doi: 10.1186/s13023-014-0111-y

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014 Liu et al.; licensee Biomedcentral Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

In IVS4 + 919G > A Fabry disease patients, the baseline and last follow-up LVMI (A)(C) as well as baseline, first and last follow-up serum lyso-Gb3 results (B)(D) were shown in mean ± SD. There were significant decreased of LVMI between baseline and last follow-up in IVS4 + 919G > A male (A) and female (C) FD patients. Significant decreased in serum lyso-Gb3 between baseline and first follow-up results were also found in IVS4 + 919G > A male (B) and female (D) patients. However, there were no statistical significance between baseline and last follow-up serum lyso-Gb3 results in IVS4 + 919G > A male (B) or female (D) FD patients. FD: Fabry disease; LVMI: left ventricular mass index; lyso-Gb3: globotriaosylsphingosine; SD: standard deviation.